Saccharomyces cerevisiae DNA repair pathways involved in repair of lesions induced by mixed ternary mononuclear Cu(II) complexes based on valproic acid with 1,10-phenanthroline or 2,2’- bipyridine ligands

The addition of Cu (II) and the ligands to the sodium valproate molecule, contributed to increase in the cytotoxicity in relation to the putative anticancer drug sodium valproate. Also, the Cu(II) complexes presented different and interesting abilities to induce specific DNA damage, leading to recru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mutation research. Genetic toxicology and environmental mutagenesis 2021-08, Vol.868-869, p.503390-503390, Article 503390
Hauptverfasser: Rodrigues, Gabriel Berbigier, dos Santos Silveira, Priscila, Machado, Miriana, Guecheva, Temenouga Nikolova, Pich, Claus Tröger, Roesch-Ely, Mariana, Moura, Sidnei, Dumas, Françoise, de Oliveira, Iuri Marques, Henriques, João Antonio Pêgas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The addition of Cu (II) and the ligands to the sodium valproate molecule, contributed to increase in the cytotoxicity in relation to the putative anticancer drug sodium valproate. Also, the Cu(II) complexes presented different and interesting abilities to induce specific DNA damage, leading to recruitment of distinct DNA repair pathways. [Display omitted] •The Cu(II) complexes have higher cytotoxicity than sodium valproate.•Cu(II) complexes and sodium valproate induced mutations in S. cerevisiae.•BER, NER or TLS yeast strains mutants showed higher sensitivity to sodium valproate.•DNA damage induced by Cu(II) complexes requires BER, NER, HR, TLS and PRR pathways.•Cu(II) complexes display a potential application as cytotoxic agents. The sodium valproate has been largely used as an anti-epilepsy drug and, recently, as a putative drug in cancer therapy. However, the treatment with sodium valproate has some adverse effects. In this sense, more effective and secure complexes than sodium valproate should be explored in searching for new active drugs. This study aims to evaluate the cytotoxicity of sodium valproate, mixed ternary mononuclear Cu(II) complexes based on valproic acid (VA) with 1,10-phenanthroline (Phen) or 2,2’- bipyridine (Bipy) ligands - [Cu2(Valp)4], [Cu(Valp)2Phen] and [Cu(Valp)2Bipy] - in yeast Saccharomyces cerevisiae, proficient or deficient in different repair pathways, such as base excision repair (BER), nucleotide excision repair (NER), translesion synthesis (TLS), DNA postreplication repair (PRR), homologous recombination (HR) and non-homologous end-joining (NHEJ). The results indicated that the Cu(II) complexes have higher cytotoxicity than sodium valproate in the following order: [Cu(Valp)2Phen] > [Cu(Valp)2Bipy] > [Cu2(Valp)4] > sodium valproate. The treatment with Cu(II) complexes and sodium valproate induced mutations in S. cerevisiae. The data indicated that yeast strains deficient in BER (Ogg1p), NER (complex Rad1p-Rad10p) or TLS (Rev1p, Rev3p and Rad30p) proteins are associated with increased sensitivity to sodium valproate. The BER mutants (ogg1Δ, apn1Δ, rad27Δ, ntg1Δ and ntg2Δ) showed increased sensitivity to Cu(II) complexes. DNA damage induced by the complexes requires proteins from NER (Rad1p and Rad10p), TLS (Rev1p, Rev3p and Rad30p), PRR (Rad6 and Rad18p) and HR (Rad52p and Rad50p) for efficient repair. Therefore, Cu(II) complexes display enhanced cytotoxicity when compared to the sodium valproate and induce distinct DNA lesi
ISSN:1383-5718
1879-3592
DOI:10.1016/j.mrgentox.2021.503390